AstraZeneca Plc plans to build a $1.5 billion manufacturing facility in Singapore to make antibody-drug conjugates as the U.K. drugmaker pushes to beef up its ability to produce the next-generation cancer treatments. The plant will be Astra’s first drug-conjugate facility to produce the medicines from start to finish, the company said in a statement Monday.
Astrazeneca Plans $1.5 Billion Factory In Singapore As Drug Industry Splits From China
Ashleigh Furlong / Bloomberg, Time: Business
Mon, 05/20/2024 - 1:50am
Topics: astrazeneca plc chief executive officer pascal soriot china ldquo;we’re europe march bo&rsquo asia read build world&rsquo largest facility boost carbon-removal power ocean u.k gsk plc london gsk’s antibody-drug singapore&rsquo png cheong boon singapore economic development board astra singapore astra&rsquo u.s plans billion industry conjugates cancer manufacturing produce ingredient pushes supply plant start
BING NEWS:
- Siltronic Opens $2.2 Billion Wafer Fab In Singapore Amid Booming Chip Demand
Germany's Siltronic has opened a $2.2 billion wafer factory in Singapore as demand for chips used in mobile devices, electric vehicles and data centers increases.
06/12/2024 - 2:37 pm | View Link - TSMC unit, NXP of Netherlands unveil Singapore chip plant plan
An affiliate of Taiwan chip titan TSMC has joined Dutch chip maker NXP to announce plans to build a new US$7.8 billion factory in Singapore to make processors for the auto and mobile end markets.
06/5/2024 - 11:10 pm | View Link - AstraZeneca Plans to Rake in $80 Billion by 2030. Should You Buy the Stock?
To serve its goal, the company is investing $1.5 billion to construct a specialized manufacturing facility in Singapore ... to see industry-leading growth. At the same time, it plans to continue ...
05/29/2024 - 1:05 am | View Link - AstraZeneca Plans $1.5 Billion Factory in Singapore as Drug Industry Splits From China
AstraZeneca Plc plans to build a $1.5 billion manufacturing facility in Singapore to make antibody-drug conjugates as ... as the U.S. pushes to reduce the industry’s reliance on China.
05/19/2024 - 9:50 pm | View Link - AstraZeneca to Build $1.5 Billion Drug Plant in Singapore
(Bloomberg) -- AstraZeneca Plc plans to build a $1.5 billion manufacturing facility in Singapore to make antibody-drug conjugates ... the US pushes to reduce the industry’s reliance on China.
05/19/2024 - 8:55 pm | View Link - More
Welcome to Wopular
Wopular is an
online newspaper rack,
giving you a summary view of the top headlines from the top news sites.
Senh Duong (Founder)
Wopular,
MWB,
RottenTomatoes
MoviesWithButter : Our Sister Site
- "Expendables 4" Starts Shooting This Fall, Says Randy Couture at the Arnold Sports Festival more
- “Expendables 4” Gets Funding Interest from “Ip Man 3” Financier more
- "Ip Man 3" Distributor Suspected of Box Office Fraud, Parent Company Loses $200M in Market Cap more
- Yen Targets "Ip Man 4" for 2018 Release; Discusses Film with Director, Producer more
- "Ip Man 3" Shatters Expectations with $72M Opening [China Box Office] more